Back

Clinical Characteristics in Children and Adolescents with SARS-CoV-2 Infection: Experience in a highly complex Public Hospital in the city of Sao Paulo

Vieira, R. S. R.; Aguiar, E. L. d.; Evangelista, N. M. d. A.; Sarrubbo, S. A. B.; Verlangieri, H. A. R.; Otsuka, M.

2020-07-19 pediatrics
10.1101/2020.06.22.20136994 medRxiv
Show abstract

ObjectiveFaced with the SARS-CoV-2 epidemic, the real impact of the disease on children and adolescents and the behavior of the disease in this population are questioned. This study aims to assess the clinical characteristics of children and adolescents with SARS-CoV-2 infection and the effectiveness of the measures adopted at the institution. MethodsThis is a prospective study carried out from 11/04/2020 to 19/06/2020. Investigated 346 patients between zero and eighteen years old, with analysis of patients diagnosed with COVID-19 confirmed by RT-PCR, obtained from a nasopharynx and oropharynx swab, attended at a highly complex public pediatric hospital in the city of Sao Paulo. Protocols for clinical management and treatment of cases of SARS-CoV-2 infection were adopted during the assistance and implementation of a preoperative screening protocol. They were evaluated according to sex, age, epidemiology, presence of comorbidities, clinical manifestations, therapy used, need for hospitalization in the ward and ICU, use of mechanical ventilation (MV) and evolution. Results66 confirmed patients with COVID 19 were identified. Median age was 7 years old, with the male gender predominant (2:1). 27 patients (40.9%) had contact with symptomatic respiratory individuals, comorbidity occurred in 50 cases (75.8%). Main clinical manifestations were: fever, 37 patients (56.1%); cough, 23 (34.8%); respiratory distress in 10 (15.2%) and gastrointestinal symptoms in 24 (36.4%). 38 patients (57.6%) received antibiotics and 13 (19.7%) received corticotherapy. 37 patients (56.1%) required hospitalization, eight (19.5%) in the ICU and six (75%) requiring MV. One death occurred and others with good evolution. ConclusionThis study corroborates the perception that the pediatric patient has a more benign manifestation, even in the presence of comorbidities, requiring the screening of surgical patients. The protocol adopted by the institution proved to be effective, with no contamination being observed among patients or between patients and collaborators.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Pediatric Infectious Disease Journal
16 papers in training set
Top 0.1%
22.6%
2
PLOS ONE
4510 papers in training set
Top 9%
18.6%
3
Frontiers in Pediatrics
29 papers in training set
Top 0.1%
10.1%
50% of probability mass above
4
BMJ Paediatrics Open
21 papers in training set
Top 0.1%
6.3%
5
Cureus
67 papers in training set
Top 1.0%
4.0%
6
Pediatric Pulmonology
14 papers in training set
Top 0.1%
4.0%
7
Scientific Reports
3102 papers in training set
Top 47%
2.5%
8
Pediatrics
10 papers in training set
Top 0.1%
2.4%
9
Vaccines
196 papers in training set
Top 1.0%
2.1%
10
Medicine
30 papers in training set
Top 1.0%
1.8%
11
PLOS Neglected Tropical Diseases
378 papers in training set
Top 3%
1.7%
12
BMJ Open
554 papers in training set
Top 9%
1.7%
13
Archives of Clinical and Biomedical Research
28 papers in training set
Top 0.9%
1.5%
14
Pediatric Research
18 papers in training set
Top 0.3%
1.2%
15
Journal of Hospital Infection
27 papers in training set
Top 0.4%
1.2%
16
Eurosurveillance
80 papers in training set
Top 1%
1.2%
17
Annals of Translational Medicine
17 papers in training set
Top 0.9%
1.2%
18
BMC Infectious Diseases
118 papers in training set
Top 4%
1.1%
19
The Journal of Pediatrics
15 papers in training set
Top 0.5%
1.0%
20
Journal of Clinical Pathology
12 papers in training set
Top 0.3%
1.0%
21
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 3%
1.0%
22
Journal of Medical Virology
137 papers in training set
Top 5%
0.6%
23
JMIRx Med
31 papers in training set
Top 2%
0.6%
24
Archives of Disease in Childhood
15 papers in training set
Top 0.5%
0.6%